CLINICAL EVALUATION OF MUSTADI GHANVATI IN AMAVATA (RHEUMATOID ARTHRITIS)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- RELIEF IN SUBJECTIVE PARAMETERS :-
研究概览
简要总结
THIS IS AN OPEN LABEL CLINICAL STUDY TO EVALUATE THE EFFECT OF MUSTADI GHANVATI IN AMAVATA (RHEUMATOID ARTHRITIS). It will be a clinical study of 30 patients suffering from rheumatoid arthritis. Patient will be randomly selected irrespective of their gender, race, religion, occupation.-Patient with classical features of Amavata attending the OPD and IPD of Kayachikitsa department of Quadra institute of Ayurveda,Roorkee will be selected for this clinical study.The patients between the age group of 20 to 50 years of age.The assessment of the trial will be done on the basis of subjective and objective parameters .The period of study is 18 months and duration of study is 45 days . Data depending upon above subjective and objective criteria and other variables will be collected and analyzed statistically.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient willing to participate in the trial and sign the consent form.
- •Patients of Rheumatoid arthritis with features mentioned in subjective parameters.
- •The patients between the age group of 20 to 50 years of age.
- •Patients having classical features of Amavata like Angamarda, Aruchi,Trishna, Hrillasa, Alasya, Gaurava, Jwara, Shoola, Shotha.
- •5..Patients must fulfill the criteria for rheumatoid arthritis outlined by the 2010 ACR (American College of Rheumatology) and EULAR (European League Against Rheumatism).
排除标准
- •1.Patient not willing for trial.
- •Patient below the age of 20 years and above 50 years.
- •3.Patients having Severe crippling bone deformity 4.Patients having another type of arthropathy such as Gout, Ankylosing spondylitis etc.
- •Juvenile rheumatoid arthritis, Severely deformed joints, with genetic and endocrinal disorder, or any other chronic illness.
- •Patients taking antibiotic therapy for any systemic illness within 2 months, Pregnant women and lactating mother.
- •Any other patient considered unfit for inclusion in trial after investigation.
结局指标
主要结局
RELIEF IN SUBJECTIVE PARAMETERS :-
时间窗: First follow up- after 15 days of first trial | Second follow up - 15 days after first follow up. | Third follow up- 15 days after second follow up
1.PAIN
时间窗: First follow up- after 15 days of first trial | Second follow up - 15 days after first follow up. | Third follow up- 15 days after second follow up
2.SWELLING
时间窗: First follow up- after 15 days of first trial | Second follow up - 15 days after first follow up. | Third follow up- 15 days after second follow up
3.STIFFNESS
时间窗: First follow up- after 15 days of first trial | Second follow up - 15 days after first follow up. | Third follow up- 15 days after second follow up
4.TENDERNESS
时间窗: First follow up- after 15 days of first trial | Second follow up - 15 days after first follow up. | Third follow up- 15 days after second follow up
5.GENERAL SYMPTOMS
时间窗: First follow up- after 15 days of first trial | Second follow up - 15 days after first follow up. | Third follow up- 15 days after second follow up
次要结局
- RELIEF IN OBJECTIVE PARAMETERS :-(1.JOINT INVOLVEMENT)
研究者
Diksha Thakur
Quadra Institute Of Ayurveda And Hospital Roorkee